NDC 51672-1386-01 - Fluocinonide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51672-1386
- Requested NDC
- 51672-1386-01
- Package NDCs from labels
- 51672-1386-1, 51672-1386-2, 51672-1386-3, 51672-1386-4, 51672-1386-01
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2025-12-06
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Fluocinonide - A-S Medication Solutions | A-S Medication Solutions | 2025-12-06 | HUMAN PRESCRIPTION DRUG LABEL |
| Fluocinonide Cream USP, 0.05% | Sun Pharmaceutical Industries, Inc. | Sun Pharma Canada Inc. | 2025-07-08 | HUMAN PRESCRIPTION DRUG LABEL |
| Fluocinonide - RedPharm Drug | RedPharm Drug | 2024-08-07 | HUMAN PRESCRIPTION DRUG LABEL |
| Fluocinonide Cream USP, 0.05% | NuCare Pharmaceuticals,Inc. | 2024-06-14 | HUMAN PRESCRIPTION DRUG LABEL |
| Fluocinonide Cream USP, 0.05% | NuCare Pharmaceuticals Inc. | 2024-06-06 | HUMAN PRESCRIPTION DRUG LABEL |
| Fluocinonide Cream USP, 0.05% | RPK Pharmaceuticals, Inc. | 2022-03-30 | HUMAN PRESCRIPTION DRUG LABEL |
| Fluocinonide - A-S Medication Solutions | A-S Medication Solutions | 2021-03-01 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51672-1386-1 | Fluocinonide | 15 g in 1 TUBE | CREAM | 15 | 3 | |
| 51672-1386-1 | Fluocinonide | 1 in 1 CARTON | CREAM | 1 | 3 | |
| 51672-1386-2 | Fluocinonide | 30 g in 1 TUBE | CREAM | 30 | 3 | |
| 51672-1386-2 | Fluocinonide | 1 in 1 CARTON | CREAM | 1 | 3 | |
| 51672-1386-3 | Fluocinonide | 60 g in 1 TUBE | CREAM | 60 | 3 | |
| 51672-1386-3 | Fluocinonide | 1 in 1 CARTON | CREAM | 1 | 3 | |
| 51672-1386-4 | Fluocinonide | 120 g in 1 TUBE | CREAM | 120 | 3 | |
| 51672-1386-4 | Fluocinonide | 1 in 1 CARTON | CREAM | 1 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51672-1386 | FLUOCINONIDE CREAM [TARO PHARMACEUTICALS U.S.A., INC.] | 1 | Current NDC, Legacy NDC, 8 package rows | 20161118_5782d791-48fd-4cee-853d-235eb4d04a40.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 51672-1386-1 | GM - Gram | 51672-1386 | 94eaa54a-220f-4e16-a8cb-eb3c6fd2a84e | 1 | 2017-04-05 |
| 51672-1386-2 | GM - Gram | 51672-1386 | e709049c-b525-42c0-9c77-65fd58599d8f | 1 | 2017-04-05 |
| 51672-1386-3 | GM - Gram | 51672-1386 | 56fc2100-c2f3-4fc5-9602-8739f611c568 | 1 | 2017-04-05 |
| 51672-1386-4 | GM - Gram | 51672-1386 | 73d0a0da-2a64-4d2b-be5a-dfdfa3e5a4a2 | 1 | 2017-04-05 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Petrochemical Detox | CHELIDONIUM MAJUS, TARAXACUM OFFICINALE, TRIFOLIUM PRATENSE, SYMPHYTUM OFFICINALE, ACETONE, SODIUM TRIPOLYPHOSPHATE, PROPYLENE GLYCOL, BENZINUM, AMMONIUM MURIATICUM, SODIUM LAURYL SULFATE, TEREBINTHINA, ARSENICUM ALBUM, CADMIUM SULPHURATUM, GELSEMIUM SEMPERVIRENS, IRIDIUM METALLICUM, LYCOPODIUM CLAVATUM, MERCURIUS SOLUBILIS, NITRICUM ACIDUM, NUX VOMICA, PETROLEUM, PHOSPHORICUM ACIDUM, PLATINUM METALLICUM, LATRODECTUS MACTANS | Deseret Biologicals, Inc. | b38b492a-cf45-4aa2-ba7e-4573d2c4ebe5 | 2023-01-12 | Warnings | 6DC9Q167V3 |
| Fluocinonide | FLUOCINONIDE | Cosette Pharmaceuticals, Inc. | e3348b90-8c16-4788-ab61-e354aea5d0a8 | 2022-12-27 | Adverse reactions | 103456 2W4A77YPAN |
| Fluocinonide | FLUOCINONIDE | Asclemed USA, Inc. | b387f926-1109-41b2-9fe0-f77db6b10280 | 2022-12-13 | Warnings, Adverse reactions | 2W4A77YPAN |
| basic care clearlax | POLYETHYLENE GLYCOL 3350 | Amazon.com Services LLC | 21897170-0d5e-4326-bebf-10258e0aca82 | 2022-12-08 | Warnings | G2M7P15E5P |
| Refresh Digital PF | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN AND POLYSORBATE 80 | Allergan, Inc. | 97e83e68-6374-4df4-93f6-d707fc32748d | 2022-11-28 | Warnings | PDC6A3C0OX |
| Refresh Digital | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, POLYSORBATE 80 | Allergan, Inc. | b2bd34d4-fab9-4f4b-9be2-5d30b55f5b81 | 2022-11-28 | Warnings | PDC6A3C0OX |
| POLYETHYLENE GLYCOL 3350 | POLYETHYLENE GLYCOL 3350 | Geri-Care Pharmaceutical Corp | f4c7eb80-d8d5-406d-90d0-9d17914d71f2 | 2022-11-24 | Warnings | G2M7P15E5P |
| Polyethylene Glycol 3350 | POLYETHYLENE GLYCOL 3350 | Gericare Pharmaceuticals | 5d0d2c14-24e6-45b4-92f6-4eaf5da72cdd | 2022-10-28 | Warnings | G2M7P15E5P |
| FLUOCINONIDE | FLUOCINONIDE | Viona Pharmaceuticals Inc | 248675bd-c797-46ab-adf9-f37352c33059 | 2022-10-04 | Warnings, Adverse reactions | 2W4A77YPAN |
| Fluocinonide | FLUOCINONIDE | Zydus Pharmaceuticals USA Inc. | 73315c87-4e55-41ea-883b-23d504c1b10d | 2022-10-04 | Adverse reactions | 2W4A77YPAN |
| REFRESH OPTIVE | CARBOXYMETHYLCELLULOSE SODIUM AND GLYCERIN | Allergan, Inc. | 7f8d88af-fd3b-4138-af61-f24c59ccebd7 | 2022-09-23 | Warnings | PDC6A3C0OX |
| REFRESH OPTIVE Advanced | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, POLYSORBATE 80 | Allergan, Inc. | ebd0839e-2e1d-4e0e-986c-19f1f5c76358 | 2022-09-15 | Warnings | PDC6A3C0OX |
| Equate ClearLAX | POLYETHYLENE GLYCOL 3350 | WALMART INC. | c5c13378-3c08-415f-8ab4-8a18d6300ca8 | 2022-09-08 | Warnings | G2M7P15E5P |
| REFRESH OPTIVE Advanced | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, AND POLYSORBATE 80 | Allergan, Inc. | aaa943e4-7c38-4c5a-b7c0-5a656d8cafc0 | 2022-09-01 | Warnings | PDC6A3C0OX |
| injoy constipation relief | POLYETHYLENE GLYCOL 3350 | L. Perrigo Company | b2414517-04bf-4f29-951e-b867855078c3 | 2022-08-19 | Warnings | G2M7P15E5P |
| Glycerinum | GLYCERINUM | Hahnemann Laboratories, INC. | e34f8796-85b5-2946-e053-2995a90a251e | 2022-07-08 | PDC6A3C0OX | |
| Good Sense Clear Lax | POLYETHYLENE GLYCOL 3350 | Proficient Rx LP | 0858a914-4812-4e4d-82f8-ecf93d43ef3b | 2022-07-01 | Warnings | G2M7P15E5P |
| REFRESH Optive Mega-3 | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN AND POLYSORBATE 80 | Allergan, Inc. | c5f2b3f2-2071-45bd-a010-67f848bc0233 | 2022-06-30 | Warnings | PDC6A3C0OX |
| GAVILAX | POLYETHYLENE GLYCOL 3350 | Proficient Rx LP | 199d6173-3fad-49e4-88fe-bde7223ed4c3 | 2022-06-01 | Warnings | G2M7P15E5P |
| 28c867b0-31db-487d-8df1-cf5dad9c044a | d823803c-a125-4695-a04b-6c14b6a66ab6 | 2022-03-30 | Adverse reactions | 28c867b0-31db-487d-8df1-cf5dad9c044a d823803c-a125-4695-a04b-6c14b6a66ab6 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.